Blood Pressure and Cardiometabolic Risk (Diet-to-HTN)
1 other identifier
interventional
50
1 country
1
Brief Summary
Obesity is a significant health issue that increases the risk of serious cardiovascular problems. In recent years, two dietary methods, the Ketogenic Diet (KD) and Intermittent Fasting (IF), have become popular for their potential to treat obesity and its related issue, hypertension. While both diets are known for their effectiveness in weight loss, their specific impacts on blood pressure (BP) and overall heart health risks are less understood especially in menopausal women. The main goal of this study was to investigate how the Ketogenic Diet and Intermittent Fasting compare to a regular, unrestricted diet (referred to as Free Diet or FD) in terms of their effects on clinic blood pressure levels in menopausal women. Additionally, the study looked at changes in Body Mass Index (BMI), the percentage of total body weight loss, body fat percentage, waist and hip measurements, the ratio of waist-to-hip size, and the Phase Angle (PhA), which is a measure of the body's overall health status.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 22, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 22, 2023
CompletedFirst Submitted
Initial submission to the registry
June 1, 2024
CompletedFirst Posted
Study publicly available on registry
June 13, 2024
CompletedJuly 16, 2024
July 1, 2024
1 year
June 1, 2024
July 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinic systolic brachial BP levels.
The primary aim was to evaluate the effects of Very low calorie Ketogenic Diet or intermittent fasting compared to Free Diet on clinic systolic brachial BP levels (mmHg).
6 months
Secondary Outcomes (5)
Body composition: BMI
6 months
Body composition: Fat mass (%)
6 months
Body composition: circumference
6 months
Body Composition: Bioelectrical impedance analysis (BIA)
6 months
Clinic diastolic brachial BP levels.
6 months
Study Arms (3)
Free diet Group (FDG)
OTHERparticipants were offered nutritional guidance without strict limitations, but were encouraged to adhere to the principles of the Mediterranean diet and follow the dietary recommendations outlined in Harvard's Healthy Eating Plate.
Very low Calorie Ketogenic Diet Group (VLCKDG)
EXPERIMENTALthe very low-calorie ketogenic diet (VLCKD) protocol involved limited carbohydrate consumption to less than 30 grams per day. The protocol suggested a protein intake ranging from 1 to 1.5 grams per kilogram of ideal body weight, with fats limited to 15-30 grams per day and total daily calories estimated between 600 and 800 kcal. During the initial three-week phase of the diet, participants replaced two meals per day with meal replacements-specifically, breakfast and one other main meal were substituted with a protein shake. Accompanying the shake for the main meal were low-glycemic-index vegetables in prescribed quantities.
Intermittent Fasting Group (IFG)
ACTIVE COMPARATOROur participant followed an intermittent fasting schedule, specifically the 16/8 method, which involves eating only during an eight-hour window each day and fasting for the subsequent sixteen hours. This eating period began at 12:00 noon and ended at 8:00 PM. During this window, the patient consumed three meals, each with a caloric value reduced by 25% from their total daily energy expenditure. The meals were based on the Mediterranean diet, focusing on the balance and quality of macronutrients.
Interventions
Participants were offered nutritional guidance and were encouraged to adhere to the principles of the Mediterranean diet and follow the dietary recommendations outlined in Harvard's Healthy Eating Plate.
Participants were offered nutritional guidance and were encouraged to adhere to the principles of the very low-calorie ketogenic diet (VLCKD) protocol
Participants were offered nutritional guidance and were encouraged to adhere to the principles of the intermittent fasting schedule
Eligibility Criteria
You may qualify if:
- female individuals,
- aged between 50 and 65 years,
- BMI ≥25 kg/m2;
- diagnosis of essential uncomplicated arterial hypertension for at least 6 months;
- perimenopause or menopause confirmed,
- provision of informed consent.
You may not qualify if:
- previous history of major CVDs;
- severe heart or renal failure;
- poor adherence to prescribed pharmacological and non-pharmacological treatments;
- treated uncontrolled hypertension or diabetes;
- secondary forms of hypertension;
- uncontrolled thyroid diseases;
- previous bariatric surgery or endoscopic bariatric procedures;
- regular engagement in competitive sports activities;
- history of alcoholism and/or drug addiction;
- psychiatric and/or neurological conditions affecting the understanding and giving of informed consent;
- cancer or any other progressive severe disease;
- use of pharmacological treatments known to may interfere with the main purposes of the study protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sapienza University of Rome
Rome, RM, 00189, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Masking Details
- Collaborative consultation encouraged patients to participate. Patient can choose their group of intervention. Dietary regimen were tailored on each patient: the intervention was adapted to patients' needs and to their body composition.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Cardiology
Study Record Dates
First Submitted
June 1, 2024
First Posted
June 13, 2024
Study Start
June 22, 2022
Primary Completion
June 22, 2023
Study Completion
June 22, 2023
Last Updated
July 16, 2024
Record last verified: 2024-07